Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
admin Eisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker and…
Read MoreHealthcare/Life Sciences
Alzheimer’s drug from Eisai, Biogen shows promise in large trial
Eisai Co. 4523, +0.89% and Biogen Inc. BIIB, +1.04% said their experimental Alzheimer’s disease drug…
Read MoreOpinion: Feeding people on this warming Earth requires future-proofing our agri-food systems. Here’s how.
These days, it is easy to feel overwhelmed. A worsening regional conflict in Ukraine, overlain…
Read MoreMelt Pharmaceuticals files for IPO
Melt Pharmaceuticals, Inc. filed for an initial public offering with the Securities and Exchange Commission…
Read MoreFDA warns ‘NyQuil chicken’ is ‘a recipe for danger’
What the actual cluck? The latest seriously questionable social-media trend apparently has people sautéing chicken…
Read MoreRoche’s vision-loss drug Vabysmo gets EU nod
Roche Holding AG said Monday that its vision-loss treatment Vabysmo has been approved in the…
Read MoreMarket rout casts cloud over biggest IPO of the year as at least two deals are pulled during brutal selloff
At least two initial public offerings were withdrawn during Tuesday’s brutal stock market rout, casting…
Read MoreCan nasal vaccines help prevent COVID-19 infections—or transmission?
The news earlier this week that China and India plan to roll out nasal vaccines…
Read MoreNovartis to spin off, list Sandoz business
Novartis AG is planning to spin off its generics-and-biosimilars division Sandoz and list it as…
Read MoreWhat will insurance coverage of COVID-19 vaccines and treatments look like? The Biden administration is trying to figure that out
Get ready for a big change in how the U.S. will pay for COVID-19 vaccines…
Read More